We develop a model of treatment response in patients with advanced prostate cancer (APC), based on measurements of median Apparent Diffusion Coefficient (ADC) and tumour Diffusion Volume (tDV) derived using Whole-Body Diffusion Weighted Imaging (WBDWI) and blood biomarkers. The model showed that change in ADC is positively correlated with response in this patient population. Furthermore, our model predicted response with an accuracy of 87%, and sensitivity/specificity of 75/93% using a probability cut-off of 0.5.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords